Mariusz K.
- Country
- Poland
- Department
- Oddział Kliniczny Reumatologii,Immunologii i Chorób Wewnętrznych Z Poradnią Reumatologiczną
Research Overview
- Evaluation of Long-Term Safety and Efficacy of Litifilimab in Adults with Active Systemic Lupus Erythematosus: A Phase 3 Multicenter, Randomized, Dose-Blind Study
- Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Nonbiologic Standard of Care: A Phase 3 Randomized Controlled Trial
Data & Insights
Has run more than one trial at 315 of 588 partner sites.
Specializations
Autoimmune Rheumatic Conditions
Specializes in investigating novel treatments for systemic lupus erythematosus (SLE) and Sjögren's syndrome, with particular emphasis on innovative biological therapies.
- Advanced SLE Therapeutics
- Sjögren's Syndrome Management
- Long-term Disease Control
Focuses on evaluating long-term safety and efficacy of emerging therapeutic agents for autoimmune disorders.
Inflammatory Arthritis
Conducts research in psoriatic arthritis and rheumatoid arthritis, exploring both conventional and biosimilar treatment approaches.
- Psoriatic Arthritis Interventions
- Biosimilar Development
- Disease Activity Assessment
Evaluates novel therapeutic agents targeting specific inflammatory pathways in arthritic conditions.
Spondyloarthritis Studies
Leads investigations in axial spondyloarthritis and related conditions, with expertise in both radiographic and non-radiographic disease variants.
- Early Disease Intervention
- Treatment Response Monitoring
- Long-term Disease Management
Specializes in evaluating innovative treatments for various forms of spondyloarthritis.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.